regenxbio - Robuta Search

https://www.biospace.com/fda/fda-action-alert-sanofi-regeneron-merck-regenxbio-and-more FDA Action Alert: Sanofi/Regeneron, Merck, REGENXBIO and More - BioSpace Feb 2, 2026 - In what is shaping up to be a back-loaded month, the FDA is set to release a slew of regulatory decisions in February, including two that would expand the... action alert fda sanofi regeneron merck https://www.biospace.com/policy/regenxbio-secures-legal-win-in-gene-therapy-patent-battle-vs-sarepta REGENXBIO Secures Legal Win in Gene Therapy Patent Battle Vs. Sarepta - BioSpace Feb 23, 2026 - A lower court had previously ruled for Sarepta in the companies’ long-running dispute, finding that REGENXBIO’s AAV patent was invalid because its elements... secures legal gene therapy patent battle regenxbio win https://www.biospace.com/drug-development/denalis-hunter-syndrome-candidate-in-the-spotlight-after-regenxbio-rejection Denali’s Hunter Syndrome Candidate in the Spotlight After REGENXBIO Rejection - BioSpace Mar 16, 2026 - The Hunter syndrome space suffered a setback in February when the FDA turned down REGENXBIO's investigational gene therapy, raising urgent questions about... hunter syndrome candidate spotlight regenxbio rejection